Cipemastat | Interleukin Related interleukin-related.com

Product Name :
Cipemastat

Search keywords :
Cipemastat

drugId :
null

Target Vo:
Metalloproteases

Target Vo Short Name :
Metalloproteases

Moa_Name:
Metalloproteases inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
F. Hoffmann-La Roche Ltd

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Arthritis, Rheumatoid

Termination Status :
Phase 3 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-p38 (Thr180+Tyr182) Antibody supplier
HDAC4 (4A3) Mouse mAb medchemexpress
Pyruvate Dehydrogenase E1 alpha Antibody (YA681): Pyruvate Dehydrogenase E1 alpha Antibody (YA681) is a non-conjugated and Mouse origined monoclonal antibody about 43 kDa, targeting to Pyruvate Dehydrogenase E1 alpha (3H2). It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts